In the latest episode of the BBC’s show, “Trust me, I’m a Doctor”, an innovative new product called Magseed is being trialled to improve surgery for women with breast cancer. A tiny magnetic seed is being used to transform how cancerous tissue is localised so that it can be removed, rather than using traditional guide wires. This helps the surgeons pinpoint exactly where they need to operate, and which angle is the best to approach the tumour. Much smaller tumours are currently being detected through the breast cancer screening programme, which are more difficult to find during surgery using guide wires.
Our Managing Director, Dr Elisabeth Adams, will be presenting “Mapping the diagnostic pathway for breast cancer in England and comparison to Europe” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Milan event which runs from the 7 – 11 November, 2015.
Our managing director, Dr Elisabeth Adams, is presenting two posters at the 30th annual International Papillomavirus Conference in Lisbon, Portugal. The first poster, “Exploring the value of a rapid, on-demand test for the detection of human papillomavirus”, is a detailed look at the current patient pathways for cervical screening programmes, and key opinion leaders’ views on the impact a rapid diagnostic would have on the health and overall wellbeing of women.
Optimising cancer pathways
Pathways for the diagnosis, treatment and follow-up of patients with cancer are complex. Cancer care information is held in different sites, making a holistic view to care challenging. We visualise the different routes to diagnosis and treatment, and quantify the burden to the healthcare system. This provides a more complete understanding of the opportunities for introducing innovation and improvement into cancer care resulting in better outcomes for patients and more efficient services.